Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Significant Insider Selling at One Liberty Properties Amid Strategic Pivot

Andreas Sommer by Andreas Sommer
September 4, 2025
in Analysis, Insider Trading, Real Estate & REITs
0
One Liberty Properties Stock
0
SHARES
218
VIEWS
Share on FacebookShare on Twitter

A key executive at real estate investment trust One Liberty Properties is preparing to divest a substantial number of shares. This move comes shortly after market analysts revised their price target for the company downward, even as the firm aggressively executes a strategic shift toward industrial properties.

Analyst Downgrade Precedes Major Share Sale

Market sentiment toward One Liberty Properties faced a headwind on August 29, 2025, when analysts issued a reduced price target. The new target of $26.67 represents an 8.0% decrease, signaling a recalibration of the company’s valuation prospects. This downgrade reflects a more cautious outlook on the REIT’s near-term performance.

Shortly after this adjustment, Lawrence Ricketts Jr., Executive Vice President and Chief Operating Officer, filed a Form 144 with plans to sell 20,771 common shares. The transaction, valued at approximately $489,231.83, is scheduled to be executed on the NYSE. This follows a previous sale by Ricketts Jr. in June 2025, which involved shares worth roughly $389,000.

Aggressive Push into Industrial Real Estate

Concurrent with these developments, One Liberty Properties is actively reshaping its portfolio. The company’s strategic refocus on industrial assets is advancing at a significant pace, underscored by two major acquisition phases in 2025.

Should investors sell immediately? Or is it worth buying One Liberty Properties?

  • The first quarter saw the acquisition of four industrial properties for a combined $88.3 million.
  • This was followed in Q2 by the purchase of an additional industrial facility in Blythewood, South Carolina, for $24.0 million.
  • Total investment in this strategic expansion reached over $112 million by the close of the second quarter.

To fund this pivot and streamline its holdings, the company is divesting non-core assets. Three retail properties were sold in the second quarter, generating a profit of $6.5 million. Additional sales in Colorado and Oregon are anticipated before the end of the 2025 fiscal year.

Mixed Quarterly Financial Results

The company’s second-quarter 2025 earnings report presented a nuanced financial picture. One Liberty Properties posted a 12.3% increase in rental revenue, which climbed to $24.5 million. Key profitability metrics also showed improvement, with Funds from Operations (FFO) per diluted share advancing 4.7% to $0.45. Similarly, Adjusted Funds from Operations (AFFO) per share rose 2.1% to $0.49.

However, these gains were partially offset by challenges elsewhere. Net income declined to $8.4 million, or $0.39 per share, compared to $9.6 million, or $0.45 per share, in the same period last year. This contraction was primarily driven by increased interest expenses and a rise in the weighted-average number of outstanding shares by approximately 292,000.

Despite the pressure on net income, the company reaffirmed its commitment to shareholder returns. One Liberty Properties recently declared a quarterly cash dividend of $0.45 per share, continuing its history of consistent distributions.

Ad

One Liberty Properties Stock: Buy or Sell?! New One Liberty Properties Analysis from February 7 delivers the answer:

The latest One Liberty Properties figures speak for themselves: Urgent action needed for One Liberty Properties investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

One Liberty Properties: Buy or sell? Read more here...

Tags: One Liberty Properties
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Repay Holdings Stock
Analysis

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Potbelly Stock
Analysis

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

February 7, 2026
Next Post
Koppers Stock

Koppers Shares Face Continued Analyst Pressure Following Disappointing Quarter

Impinj Stock

Impinj Stock Surges Following Strategic $150 Million Convertible Note Offering

Golden Entertainment Stock

Golden Entertainment Shares Slide Following Unexpected Q3 Loss Forecast

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com